Clin2
NCT06396013Worth exploringNot yet recruiting

Herbal nanocrystal ointment for plaque psoriasis trial

Plaque Psoriasis

Part of Skin clinical trials.

This study tests a new herbal ointment containing chitosan nanocrystals for people with stable, mild-to-moderate plaque psoriasis. The ointment is applied to the skin over 8 weeks to see if it reduces redness, scaling, and itching.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
96 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have plaque psoriasis (raised, red patches with silvery scales).
  • You are between 18 and 65 years old.
  • Your psoriasis is stable (not getting worse) and covers between 3% and 10% of your body.
  • You have not used strong psoriasis medications (like steroids, methotrexate, or biologics) in the past month to 3 months.
  • You do not have other serious health issues or infections, and are not pregnant or planning pregnancy.
  • You are willing to go to a hospital in Beijing to apply the ointment and be checked regularly.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07129382Recruiting· Phase 1/Phase 2
Study of CS32582 for moderate to severe plaque psoriasis

This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.

Beijing, Beijing Municipality
NCT06058546Recruiting· Phase 2
Jiuweihuaban pill for plaque psoriasis

This trial tests a Chinese herbal pill for people with mild-to-moderate plaque psoriasis. The pill is meant to reduce redness, scaling, and inflammation by targeting a specific pattern in traditional Chinese medicine.

Beijing
NCT07733089Recruiting· Phase 1
Testing a new psoriasis drug for safety and effect

This trial tests a new study drug (ZP9830) to see if it is safe and works well for people with plaque psoriasis. You would receive the treatment for 8 weeks, and the study will check how your skin responds.

Leiden, South Holland
NCT07158268Not yet recruiting· Phase 2
A new pill for moderate to severe plaque psoriasis

This study tests a new oral pill (HSK47388) for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing the severity and area of psoriasis over 12 weeks.

NCT07780929Recruiting
Study of XJH05 ointment for mild-to-moderate plaque psoriasis

This trial tests a new ointment (XJH05) for people with mild-to-moderate plaque psoriasis. It aims to see if this treatment helps reduce symptoms and is safe for topical use.

Xi'an, Shaanxi
NCT07410793Recruiting· Phase 2
Acupuncture plus herbal cream vs standard cream for plaque psoriasis

This trial tests if adding a Chinese herbal cream to acupuncture works as well as adding a standard psoriasis cream (calcipotriol) to acupuncture. It's for people with mild to moderate plaque psoriasis and may offer a natural treatment option.

Muang, Chiangrai

Hear when a new Plaque Psoriasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.